Clinical Trial Update: Single-arm, Single-center, Exploratory Phase II Clinical Study of Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer [Phase 2]

View source ↗

Summary

A single-arm Phase II exploratory study evaluating envafolimab with chemoradiotherapy for locally advanced pMMR/MSS rectal cancer; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Envafolimab (envafolimab)

Snippet

Sponsor: Yunnan Cancer Hospital | Conditions: Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer | Phase 2 | Status: UNKNOWN